Nifty Pharma Climbs 3% After RBI Announces Liquidity
Nifty Pharma stocks were in fast lane on Wednesday tracking all market clues. The performance in pharma stocks comes after when the RBI Governor Shaktikanta...
Tag : Biocon
Biocon Q1 Net Profit Declines 28% to Rs 149 Crore
Biocon has reported a 28 per cent drop in net profit to Rs 149 crore during the quarter to June on the back of higher research...
Biocon Net Profit During Q2 FY19 Surges 167% To Rs. 184 Crores
Biocon reported a consolidated net profit of Rs 184 crores, posting an increase of 167% for the September-end quarter of 2018, mainly on account of...
Biocon Q1 net profit rises 47% to Rs.120 crore
Biocon has reported a 47% rise in net profit at Rs.120 crore, for the quarter ended June 30,2018. The company had reported a net profit of...
Biocon receives EU GMP certification for Bengaluru facility
Biocon has received the EU GMP certification, for its sterile drug product manufacturing facility. The company stated, “We have received the European Union Good Manufacturing Practice...
Biocon’s Bengaluru Unit receives EIR from USFDA
Biocon has received Establishment Inspection Report (EIR), from the US health regulator for its manufacturing facility in Bengaluru. The EIR is received on closure of...
Biocon divests 1.88% stake in Syngene for Rs.230 crore
Biocon Ltd has divested 1.88% stake in its research arm Syngene International, for approx Rs.230 crore. In a regulatory filing the company stated, “Biocon, the promoter...
Biocon reports marginal growth of 2% in net profit for Q4
Biocon has reported approx 2% growth in its net profit at Rs.130 crore, for the quarter ended March 31,2018. The company in the same quarter last...
Biocon, Mylan enters into an in-licensing deal with Fujifilm
Biocon’s partner Mylan, has entered into an in-licensing deal to speed up commercialization of biosimilar Humira, developed by Fujifilm Kyowa Kirin Biologics for European markets. Adalimumab...
Biocon gets marketing authorization approval from European Commission
Biocon has received marketing authorization from the European Commission. Mylan N. V. and Biocon declared that their co-developed biosimilar insulin glargine Semglee, has received marketing authorization...